NCT05198557 A Study of MT-0551 in Patients With Systemic Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05177471 Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease Status WITHDRAWN Phase N/A
NCT05177380 Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis Status RECRUITING Phase NA
NCT05108857 PET Imaging of Systemic Sclerosis Using FDG and 68Ga-DOTA-Siglec-9 Status ENROLLING_BY_INVITATION Phase N/A
NCT05103553 What is the Optimal Follow-up for Patients With Systemic Sclerosis? Status NOT_YET_RECRUITING Phase NA
NCT05098704 Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk Status RECRUITING Phase PHASE2/PHASE3
NCT05078749 The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis Status UNKNOWN Phase NA
NCT05029336 Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases Status RECRUITING Phase PHASE2
NCT05016804 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis Status RECRUITING Phase PHASE1
NCT04986514 Implementation of a Biological Sample Collection in Systemic Sclerosis Patients Status WITHDRAWN Phase N/A
NCT04971018 Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis Status COMPLETED Phase NA
NCT04927390 Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) Status UNKNOWN Phase PHASE2
NCT04917705 Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies Status RECRUITING Phase NA
NCT04837131 A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients Status TERMINATED Phase PHASE2
NCT04826419 Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SSc Status COMPLETED Phase NA